Related Articles
HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer
Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan
Comparison of the IHC, FISH, SISH and qPCR methods for the molecular diagnosis of breast cancer
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma